WST stock forecast
Our latest prediction for West Pharmaceutical Services, Inc.'s stock price was made on the June 8, 2018 when the stock price was at 96.75$.
In the short term (2weeks), WST's stock price should outperform the market by 0.06%. During that period the price should oscillate between -3.33% and +3.16%.
In the medium term (3months), WST's stock price should outperform the market by 0.23%. During that period the price should oscillate between -8.15% and +9.75%.Get email alerts
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
At the moment the company generates 1711M USD in revenues.
On its last earning announcement, the company reported a profit of 2.04$ per share.
The book value per share is 17.43$
Three months stock forecastJune 8, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|